Edgewise Therapeutics, Inc.
2021 Q2 - 2025 Q4 (19 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/13/2026 | 15,171 | 0.0% | 611,384 | 12/31/2025 |
| 2025 Q3 | 11/10/2025 | 9,693 | 0.0% | 597,603 | 9/30/2025 |
| 2025 Q2 | 8/12/2025 | 7,592 | 0.0% | 579,104 | 6/30/2025 |
| 2025 Q1 | 9/15/2025 | 11,468 | 0.0% | 521,261 | 3/31/2025 |
| 2024 Q4 | 2/6/2025 | 14,347 | 0.0% | 537,359 | 12/31/2024 |
| 2024 Q3 | 11/12/2024 | 13,934 | 0.0% | 522,086 | 9/30/2024 |
| 2024 Q2 | 8/12/2024 | 10,287 | 0.0% | 571,197 | 6/30/2024 |
| 2024 Q1 | 5/9/2024 | 9,068 | 0.0% | 497,162 | 3/31/2024 |
| 2023 Q4 | 2/6/2024 | 3,622 | 0.0% | 331,059 | 12/31/2023 |
| 2023 Q3 | 11/8/2023 | 1,896 | 0.0% | 330,859 | 9/30/2023 |
| 2023 Q2 | 8/10/2023 | 2,409 | 0.0% | 310,872 | 6/30/2023 |
| 2023 Q1 | 5/12/2023 | 1,963 | 0.0% | 294,311 | 3/31/2023 |
| 2022 Q4 | 2/13/2023 | 2,654 | 0.0% | 296,875 | 12/31/2022 |
| 2022 Q3 | 11/14/2022 | 1,996 | 0.0% | 202,773 | 9/30/2022 |
| 2022 Q2 | 8/15/2022 | 918 | 0.0% | 115,252 | 6/30/2022 |
| 2022 Q1 | 5/13/2022 | 1,410 | 0.0% | 145,305 | 3/31/2022 |
| 2021 Q4 | 2/11/2022 | 2,146 | 0.0% | 140,395 | 12/31/2021 |
| 2021 Q3 | 11/16/2021 | 1,397 | 0.0% | 84,110 | 9/30/2021 |
| 2021 Q2 | 8/16/2021 | 1,730 | 0.0% | 81,074 | 6/30/2021 |